MDXG - ミメディックス・グル―プ （MiMedx Group Inc）

MiMedx Group (MDXG) is scheduled to announce Q1 earnings results on Tuesday, May 2nd, after market close.The consensus EPS Estimate is -$0.07 and the consensus Revenue Estimate is…

MARIETTA, Ga., April 18, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today announced that it will report operating and financial results for the first quarter ended March 31, 2023 after the market close on Tuesday, May 2, 2023. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 5:00 p.m. Eastern Time on the same day.

MiMedx (MDXG) said Thursday Peter Carlson will step down as the company''s chief financial officer. The company has initiated a search for its next CFO.

MiMedx Group Inc. (NASDAQ:MDXG) closed Monday at $4.26 per share, down from $4.42 a day earlier. While MiMedx Group Inc. has underperformed by -3.62%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, MDXG fell by -15.14%, with highs and lows ranging from $5.20 to $2.43, whereas […]

MiMedx Group press release (MDXG): Q4 GAAP EPS of -$0.02.Revenue of $74.38M (+10.4% Y/Y).

The following slide deck was published by MiMedx Group, Inc.

MiMedx Group press release (MDXG): Q3 GAAP EPS of -$0.09 in-line.Revenue of $67.69M (+7.3% Y/Y) beats by $0.96M.The company expects net sales for the fourth quarter 2022 to be in a…

Third Quarter Net Sales of $67.7 Million Reflect Growth of 7.3%

MiMedx Group (MDXG) is scheduled to announce Q3 earnings results on Wednesday, November 2nd, after market close.The consensus EPS Estimate is -$0.12 (-200.0% Y/Y) and the consensus…

In last trading session, MiMedx Group Inc. (NASDAQ:MDXG) saw 0.5 million shares changing hands with its beta currently measuring 1.77. Company’s recent per share price level of $2.74 trading at -$0.1 or -3.52% at ring of the bell on the day assigns it a market valuation of $328.47M. That closing price of MDXG’s stock is … MiMedx Group Inc. (NASDAQ:MDXG) Stock Plunged -54.64% So Far In 2022, What Analysts Expect Next? Read More »

In last trading session, MiMedx Group Inc. (NASDAQ:MDXG) saw 0.5 million shares changing hands with its beta currently measuring 1.77. Company’s recent per share price level of $2.74 trading at -$0.1 or -3.52% at ring of the bell on the day assigns it a market valuation of $328.47M. That closing price of MDXG’s stock is … MiMedx Group Inc. (NASDAQ:MDXG) Stock Plunged -54.64% So Far In 2022, What Analysts Expect Next? Read More »

Adds a Unique Collagen Matrix Particulate Derived from Human-Placental Tissue to the Growing $1B Surgical Recovery Market

New Product Enables Company to Target Additional Surgical Procedures and Deepen Market Penetration in the Growing $1B Surgical Recovery Market MARIETTA, Ga., Sept. 19, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced the launch of AMNIOEFFECT, a tri-layer PURION processed human tissue

Aditxt ADTX +73% after completing 1-for-50 reverse stock split.Eos Energy Enterprises (EOSE) +11%. RVL Pharmaceuticals (RVLP) +8%. MiMedx Group (MDXG) +7%. Borr Drilling (BORR) +6%

U.S. stock futures traded higher this morning ahead of the PPI data for August. Here are some big stocks recording gains in today’s pre-market trading session. MAG Silver Corp. (NYSE: MAG ) rose 8.5% to $13.78 in pre-market trading after declining around 6% on Tuesday. The company, last month, posted a rise in quarterly earnings. MiMedx Group, Inc. (NASDAQ: MDXG ) gained 5.5% to $3.65 in pre-market trading. MiMedx Group recently said that EPIFIX received reimbursement approval in Japan. Nikola Corporation (NASDAQ: … Full story available on Benzinga.com